all report title image
  • Published On : Apr 2021
  • Code : CMI4433
  • Industry : Pharmaceutical
  • Pages : 183
  • Formats :

Post-traumatic stress disorder (PTSD) is a psychiatric condition that may occur in people who have witnessed a traumatic shock like natural disaster, a life threatening event, car accident, sexual abuse etc. Symptoms of PTSD may generate after three months or even after a year. Most of the patients suffering from PTSD show symptoms like intrusive memories, avoidance, negative changes in thinking and changes in emotional and physical reactions. For instance, sudden death of a loved one may cause PTSD in some people. People with PTSD have heightened sense of danger. According to the U.S. National centre for PTSD, it is estimated that about 15% of the veterans of Vietnam War and 12% of gulf war veterans have PTSD. According to American Psychiatric Association, women are twice likely to get PTSD as compared to men. Commonly prescribed drugs for post trauma stress disorder includes antidepressants, sertraline, fluoxetine, paroxetine, and others.

Market Dynamics

The increasing number of PTSD suffering adults and teenagers across the globe is expected to drive growth of the PTSD treatment market during the forecast period. For instance, according to the U.S. Department of Veterans Affairs, about 8 million of adults who have gone gone through trauma suffer from PTSD every year. About 10% of women are found to develop PTSD sometime in their life whereas 4% men suffer from PTSD in U.S.

Lack of awareness about the post-traumatic stress disorder can resist the growth of global post-traumatic stress disorder treatment market. High cost of treatment is also a major restrain for the growth of post-traumatic stress disorder treatment market. For instance, according to the report published in the journal of Clinical Psychiatry in 2014, the cost of treatment of PTSD ranges from US$ 1,622 to US$ 4,652 per person every year in the U.S. Thus, these factors are expected to restrain the growth of global post-traumatic stress disorder treatment market.

Key features of the study:

  • This report provides in-depth analysis of the global post-traumatic stress disorder treatment market, its market size (US$ 990.7 Mn), and its compound annual growth rate (CAGR) 4.2% for the forecast period: 2022-2028, considering 2020 as the base year
  • It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by leading players
  • It profiles key players in the global post-traumatic stress disorder treatment market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies
  • Key players covered as a part of this study are Allergan PLC, AstraZeneca, Eli Lilly and Company, GlaxoSmithKline PLC, Sun Pharmaceuticals Pvt Ltd, Bristol-Myers Squibb, Johnson and Johnson, Pfizer Inc., Aurobindo Pharma., Amneal Pharmaceuticals LLC, Apotex Inc., Teva Pharmaceuticals Industries Ltd., Mylan N.V., and Bausch Health Companies Inc.
  • Insights from this report would allow marketers and management authorities of companies to make informed decisions with respect to future product launches, governmental initiatives, technological up-gradation, market expansion, and marketing tactics
  • The global post-traumatic stress disorder treatment market report caters to various stakeholders in this industry, including investors, product manufacturers, distributors, and suppliers for post-traumatic stress disorder market, research and consulting firms, new entrants, and financial analysts.

Detailed Segmentation:

  • Global Post-traumatic Stress Disorder Treatment Market, By Drug Type:
    • Antidepressants
    • Monoamine Oxidase
    • Antipsychotics or Second generation Antipsychotics
    • Beta-blockers
    • Benzodiazepines
    • Others
  • Global Post-traumatic Stress Disorder Treatment Market, By Application:
    • Adult
    • Children
  • Global Post-traumatic Stress Disorder Treatment Market, By Distribution Channel:
    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies
  • Global Post-traumatic Stress Disorder Treatment Market, By Region:
    • North America
      • By Country:
        • U.S.
        • Canada
      • By Drug Type:
        • Antidepressants
        • Monoamine Oxidase
        • Antipsychotics or Second generation Antipsychotics
        • Beta-blockers
        • Benzodiazepines
        • Others
      • By Application:
        • Adult
        • Children
      • By Distribution Channel:
        • Hospital Pharmacies
        • Retail Pharmacies
        • Online Pharmacies
    • Europe
      • By Country:
        • U.K.
        • Germany
        • Italy
        • Spain
        • France
        • Russia
        • Rest of Europe
      • By Drug Type:
        • Antidepressants
        • Monoamine Oxidase
        • Antipsychotics or Second generation Antipsychotics
        • Beta-blockers
        • Benzodiazepines
        • Others
      • By Application:
        • Adult
        • Children
      • By Distribution Channel:
        • Hospital Pharmacies
        • Retail Pharmacies
        • Online Pharmacies
    • Asia Pacific
      • By Country:
        • Australia
        • India
        • China
        • Japan
        • ASEAN
        • South Korea
        • Rest of Asia Pacific
      • By Drug Type:
        • Antidepressants
        • Monoamine Oxidase
        • Antipsychotics or Second generation Antipsychotics
        • Beta-blockers
        • Benzodiazepines
        • Others
      • By Application:
        • Adult
        • Children
      • By Distribution Channel:
        • Hospital Pharmacies
        • Retail Pharmacies
        • Online Pharmacies
    • Latin America
      • By Country:
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
      • By Drug Type:
        • Antidepressants
        • Monoamine Oxidase
        • Antipsychotics or Second generation Antipsychotics
        • Beta-blockers
        • Benzodiazepines
        • Others
      • By Application:
        • Adult
        • Children
      • By Distribution Channel:
        • Hospital Pharmacies
        • Retail Pharmacies
        • Online Pharmacies
    • Middle East
      • By Country:
        • GCC
        • Israel
        • Rest of Middle East
      • By Drug Type:
        • Antidepressants
        • Monoamine Oxidase
        • Antipsychotics or Second generation Antipsychotics
        • Beta-blockers
        • Benzodiazepines
        • Others
      • By Application:
        • Adult
        • Children
      • By Distribution Channel:
        • Hospital Pharmacies
        • Retail Pharmacies
        • Online Pharmacies
    • Africa
      • By Country/Region:
        • South Africa
        • Central Africa
        • North Africa
      • By Drug Type:
        • Antidepressants
        • Monoamine Oxidase
        • Antipsychotics or Second generation Antipsychotics
        • Beta-blockers
        • Benzodiazepines
        • Others
      • By Application:
        • Adult
        • Children
      • By Distribution Channel:
        • Hospital Pharmacies
        • Retail Pharmacies
        • Online Pharmacies
  • Company Profiles
    • Allergan PLC*
      • Company Overview
      • Product Portfolio
      • Financial Performance
      • Recent Highlights
      • Strategies
    • AstraZeneca
    • Eli Lilly and Company
    • GlaxoSmithKline PLC
    • Sun Pharmaceuticals Pvt Ltd
    • Bristol-Myers Squibb
    • Johnson and Johnson
    • Pfizer Inc.
    • Aurobindo Pharma.
    • Amneal Pharmaceuticals LLC
    • Apotex Inc.
    • Teva Pharmaceuticals Industries Ltd.
    • Mylan Pharmaceuticals
    • Bausch Health Companies Inc.

 “*” marked represents similar segmentation in other categories in the respective section.

Table of Contents

  1. Research Objectives and Assumptions
    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Overview
    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snippet, By Drug Type
      • Market Snippet, By Application
      • Market Snippet, By Distribution Channel
      • Market Snippet, By Region
    • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis
    • Drivers
    • Restraints
    • Market Opportunities
    • Impact Analysis
    • Market Trends
    • Recent Product Launches/Approvals
    • Regulatory Scenario
    • Epidemiology
    • Porter’s Analysis
    • PEST Analysis
    • Acquisition and Collaboration Scenario
  4. Global Post-traumatic Stress Disorder Treatment Market - Impact of Coronavirus (Covid-19) Pandemic
    • COVID-19 Epidemiology
    • Impact of COVID-19 on Demand and Supply
    • Government Initiative
  5. Global Post-traumatic Stress Disorder Treatment Market, By Drug Type, 2017 – 2028, (US$ Million)
    • Introduction
      • Market Share Analysis, 2021 and 2028 (%)
      • Y-o-Y Growth Analysis, 2018 – 2028
      • Segment Trends
    • Antidepressants
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018 – 2028, (US$ Million)
    • Monoamine amine Oxidase (MAO)
      •  Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018 – 2028, (US$ Million)
    • Antipsychotics or Second generation Antipsychotics (SGAs)
      •  Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018 – 2028, (US$ Million)
    • Beta- blockers
      •  Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018 – 2028, (US$ Million)
    • Benzodiazepines
      •  Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018 – 2028, (US$ Million)
    • Others
      •  Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018 – 2028, (US$ Million)
  6. Global Post-traumatic Stress Disorder Treatment Market, By Application, 2018 – 2028, (US$ Million)
    • Introduction
      • Market Share Analysis, 2021 and 2028 (%)
      • Y-o-Y Growth Analysis, 2018 – 2028
      • Segment Trends
    • Adult
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018 – 2028, (US$ Million)
    • Children
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018 – 2028, (US$ Million)
  7. Global Post-traumatic Stress Disorder Treatment Market, By Distribution Channel, 2018 – 2028, (US$ Million)
    • Introduction
      • Market Share Analysis, 2021 and 2028 (%)
      • Y-o-Y Growth Analysis, 2018 – 2028
      • Segment Trends
    • Hospital Pharmacies
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018 – 2028, (US$ Million)
    • Retail Pharmacies
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018 – 2028, (US$ Million)
    • Online Pharmacies
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018 – 2028, (US$ Million)
  8. Global Post-traumatic Stress Disorder Treatment Market, By Region, 2018 – 2028, (US$ Million)
    • Introduction
      • Market Share Analysis, By Region, 2021 and 2028 (%)
      • Y-o-Y Growth Analysis, By Region, 2018 – 2028
      • Regional Trends
    • North America
      • Market Size and Forecast, By Drug Type, 2018 – 2028, (US$ Million)
      • Market Size and Forecast, By Application, 2018 – 2028, (US$ Million)
      • Market Size and Forecast, By Distribution Channel, 2018 – 2028, (US$ Million)
      • Market Size and Forecast, By Country, 2018 – 2028, (US$ Million)
        • U.S.
        • Canada
    • Europe
      • Market Size and Forecast, By Drug Type, 2018 – 2028, (US$ Million)
      • Market Size and Forecast, By Application, 2018 – 2028, (US$ Million)
      • Market Size and Forecast, By Distribution Channel, 2018 – 2028, (US$ Million)
      • Market Size and Forecast, By Country, 2018 – 2028, (US$ Million)
        • U.K.
        • Germany
        • Italy
        • France
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • Market Size and Forecast, By Drug Type, 2018 – 2028, (US$ Million)
      • Market Size and Forecast, By Application, 2018 – 2028, (US$ Million)
      • Market Size and Forecast, By Distribution Channel, 2018 – 2028, (US$ Million)
      • Market Size and Forecast, By Country, 2018 – 2028, (US$ Million)
        • China
        • Japan
        • India
        • ASEAN
        • Australia
        • South Korea
        • Rest of Asia Pacific
    • Latin America
      • Market Size and Forecast, By Drug Type, 2018 – 2028, (US$ Million)
      • Market Size and Forecast, By Application, 2018 – 2028, (US$ Million)
      • Market Size and Forecast, By Distribution Channel Type, 2018 – 2028, (US$ Million)
      • Market Size and Forecast, By Country, 2018 – 2028, (US$ Million)
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Middle East
      • Market Size and Forecast, By Drug Type, 2018 – 2028, (US$ Million)
      • Market Size and Forecast, By Application, 2018 – 2028, (US$ Million)
      • Market Size and Forecast, By Distribution Channel Type, 2018 – 2028, (US$ Million)
      • Market Size and Forecast, By Country, 2018 – 2028, (US$ Million)
        • GCC Countries
        • Israel
        • Rest of Middle East
    • Africa
      • Market Size and Forecast, By Drug Type, 2018 – 2028, (US$ Million)
      • Market Size and Forecast, By Application, 2018 – 2028, (US$ Million)
      • Market Size and Forecast, By Distribution Type, 2018 – 2028, (US$ Million)
      • Market Size and Forecast, By Country/Region, 2018 – 2028, (US$ Million)
        • North Africa
        • Central Africa
        • South Africa
  9. Competitive Landscape
    • Company Profiles
      • Allergan PLC
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
      • AstraZeneca
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
      • Eli Lilly and Company
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
      • GlaxoSmithKline PLC
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
      • Sun Pharmaceuticals Pvt Ltd
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
      • Bristol-Myers Squibb
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
      • Johnson and Johnson
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
      • Pfizer Inc.
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
      • Aurobindo Inc.
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
      • Amneal Pharmaceuticals LLC
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
      • Apotex Inc.
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
      • Teva Pharmaceuticals Industries Ltd.
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
      • Mylan Pharmaceuticals
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
      • Bausch Health Companies Inc.
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
  10. Section
    • References
    • Research Methodology
    • About us and Sales Contact

*Browse 36 market data tables and 33 figures on "Global Post-traumatic Stress Disorder Treatment Market” - Forecast to 2028

EXISTING CLIENTELE

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients
trusted clients logo